Sollis Therapeutics' Grant

Sollis Therapeutics raised a round of funding on December 08, 2017. Investors include Ohio Third Frontier Commission.

Sollis Therapeutics is a clinical-stage biotechnology company focused on developing novel non-steroid, non-opioid analgesics. The company's first product is an extended release combination analgesic a…

Articles about Sollis Therapeutics' Grant: